The EU Joint Programme – Neurodegenerative Disease Research (JPND) is the largest global research initiative aimed at tackling the challenge of neurodegenerative diseases. JPND aims to increase coordinated investment between participating countries in research aimed at finding causes, developing cures, and identifying appropriate ways to care for those with neurodegenerative diseases.
More than 5 million Americans are living with Alzheimer's disease. Share the facts and join the fight at alz.org/facts.
Prevalence and Cause of Parkinson's Disease - Movement Disorder Center of the Colorado Neurological Institute
In this video, episode 2 of the series, we discuss the prevalence of Parkinson's disease throughout the world as well as various causes of the disease, such as environment and genetics. This unique series is designed to educate newly diagnosed patients and the general public about Parkinson's disease.
Alzheimer's Association Pioneer Award for Alzheimer's Research recipient Dennis Selkoe, M.D., explores one of the potential causes of cognitive decline in Alzheimer's disease — the beta-amyloid protein — and progress in developing treatments to target beta-amyloid.
There is no “one way” to diagnose Parkinson’s disease (PD). However, there are various symptoms and diagnostic tests used in combination. One of the most important things to remember about diagnosing PD is that there must be two of the four main symptoms present over a period of time for a neurologist to consider a PD diagnosis.
The goal of medical management of Parkinson disease is to provide control of signs and symptoms for as long as possible while minimizing adverse effects. Studies demonstrate that a patient's quality of life deteriorates quickly if treatment is not instituted at or shortly after diagnosis.
The clearest risk factor is age. In addition, researchers have identified a number of genes that cause or contribute to Parkinson's disease (PD), as well as potential environmental risk factors. A primary piece of evidence that environmental factors play a role is that the relative risk of PD is higher in industrialized countries.